Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes.
BACKGROUND
Proteinuria, one of the main manifestations of nephrotic syndrome, is an important risk factor for the progression of renal diseases. Podocyte foot processes (FPs) injury induces proteinuria in most renal diseases. The podocyte cytoskeleton plays important roles in maintaining the normal morphology of FPs. However, the underlying cytoskeletal component that initiates and regulates the dynamic changes of FPs is still unclear. Here, the involved podocyte cytoskeletal molecules were explored on different days in puromycin aminonucleoside nephropathy rats.


METHODS
Microarray analysis of isolated glomeruli was performed at Day 2, Day 10 and Day 15 in puromycin aminonucleoside nephropathy rats. Cytoskeletal genebank was established by sorting with the keyword 'cytoskeleton' from PUBMED genebank to identify the differential cytoskeleton genes. Microarray results were further confirmed by real-time PCR, western blot and double immunolabelling to validate their localizations.


RESULTS
Nine different cytoskeletal genes were found to be involved in the dynamic changes of FPs in puromycin aminonucleoside nephropathy rats, including six up-regulated (Tagln, Actr2, Dnm3, Arc, Vcl and Birc5) and three down-regulated (Krt2-7, Nebl and Tnnc1). The differential expression of transgelin, survivin, arp2, cytokeratin7 and vinculin was verified by real-time PCR and western blot. Double immunolabelling revealed that five cytoskeletal proteins indeed colocalized with podocyte specific markers synaptopodin or alpha-actinin-4. In addition, similar expression and distribution changes were detected in patients with proteinuric renal diseases and puromycin aminonucleoside-treated podocytes.


CONCLUSIONS
We identified five novel podocyte cytoskeletal proteins and found that they were associated with the dynamic changes of FPs in podocyte injury.
Miao
Jing
J
1Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Fan
Qingfeng
Q
Cui
Qinghua
Q
Zhang
Han
H
Chen
Lihong
L
Wang
Suxia
S
Guan
Na
N
Guan
Youfei
Y
Ding
Jie
J
D051377:Actin-Related Protein 2 / Q000032:analysis / Q000235:genetics; D000818:Animals; D002478:Cells, Cultured; D003598:Cytoskeletal Proteins / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D003599:Cytoskeleton / Q000502:physiology; D020869:Gene Expression Profiling; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D053552:Keratin-7 / Q000032:analysis; D007668:Kidney / Q000737:chemistry; D008297:Male; D051379:Mice; D008840:Microfilament Proteins / Q000032:analysis / Q000235:genetics; D008869:Microtubule-Associated Proteins / Q000235:genetics; D009124:Muscle Proteins / Q000032:analysis / Q000235:genetics; D050199:Podocytes / Q000502:physiology* / Q000648:ultrastructure; D011507:Proteinuria / Q000209:etiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077022:Survivin; D016596:Vinculin / Q000032:analysis / Q000235:genetics
D051377:Actin-Related Protein 2; C107489:BIRC5 protein, human; D003598:Cytoskeletal Proteins; D051034:Inhibitor of Apoptosis Proteins; D053552:Keratin-7; D008840:Microfilament Proteins; D008869:Microtubule-Associated Proteins; D009124:Muscle Proteins; D000077022:Survivin; C051615:transgelin; D016596:Vinculin